Know Cancer

or
forgot password

RANDOMISED STUDY ABOUT POTSOTERATORY PAIN CONTROL IN LAPAROSCOPIC SIGMOIDECTOMY


Phase 3
18 Years
90 Years
Not Enrolling
Both
Sigmoidal Tumour

Thank you

Trial Information

RANDOMISED STUDY ABOUT POTSOTERATORY PAIN CONTROL IN LAPAROSCOPIC SIGMOIDECTOMY


Inclusion Criteria:



- Age more than 18

- Laparoscopic sigmoidectomy

- Informed consent firmed

Exclusion Criteria:

- ASA IV

- Urgent surgery

- Sigmoid tumour stage IV

- Cronic pain treatment

- No informed consent firmed

- Paliative surgery

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

EVA (POSTOPERATIVE PAIN)

Outcome Description:

The investigators asked the patient the postoperative pain during teh first 72 hours by EVA scale.

Outcome Time Frame:

72 H POSTOPERATIVE

Safety Issue:

Yes

Principal Investigator

PUJOL GEMMA, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Corporacion Parc Tauli

Authority:

United States: Food and Drug Administration

Study ID:

CIR TAP 2013

NCT ID:

NCT01825993

Start Date:

April 2013

Completion Date:

April 2015

Related Keywords:

  • Sigmoidal Tumour
  • Peridural catheter
  • Morphine PCA
  • Transabdominal Block
  • laparoscopic sigmoidectomy

Name

Location